Lifestyle medicine and brain health: Insights from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) and the promise of personalization

The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a landmark 2-year randomized clinical trial evaluating multidomain lifestyle interventions for dementia prevention in older adults at elevated risk. Its effectiveness and national reach represent an important step towards scaling prevention science in diverse, real-world settings. However, the trial also underscores a persistent challenge in lifestyle medicine: the prioritization of feasibility over optimization. In this commentary, we review U.S. POINTER through a precision medicine lens and outline strategies to integrate standardized core elements with flexible, individualized components that can amplify both potency and applicability. We emphasize three priorities: (1) tailoring interventions to drive physiological adaptations; (2) leveraging the synergistic potential of related behavioral domains; and (3) targeting sleep and circadian health as central intervention components. While U.S. POINTER advances feasibility and community participation, a more tailored, mechanistically informed approach could increase effect sizes and extend benefits to populations historically excluded in prevention research. Personalized strategies should not be confined to pharmacology-they must also guide behavioral interventions. Designing lifestyle programs that stimulate measurable adaptations, leverage behavioral synergy, and align with circadian biology offers the potential to produce greater and more durable cognitive benefits. Highlights: The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) trial demonstrates that complex, multidomain interventions are feasible, acceptable, and capable of producing measurable cognitive benefits across large, heterogenous populations.While effective, U.S. POINTER produced modest effect sizes, suggesting that some components may not have been sufficiently potent or specific to elicit maximal benefits.To advance beyond feasibility, future multidomain lifestyle interventions should (1) tailor interventions to drive physiological adaptations; (2) leverage the synergistic potential of related behavioral domains; and (3) target sleep and circadian health as central intervention components.